NGM Biopharmaceuticals Inc (NGM) Insider Trading
- $111,720,295.34
- $11,048,041.52
- Jan. 30, 2023
- Group L P Column
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 30, 2023 | Director | 7,542 | $5.00 | Buy | $37,710.00 | |
Jan. 23, 2023 | Director | 9,900 | $5.00 | Buy | $49,500.00 | |
Jan. 19, 2023 | Director | 37,639 | $5.00 | Buy | $188,195.00 | |
Jan. 17, 2023 | Insider | 85,082 | $5.15 | Sell | $438,172.30 | |
Jan. 12, 2023 | Director | 5,378 | $4.95 | Buy | $26,621.10 | |
Jan. 10, 2023 | Director | 100,070 | $4.84 | Buy | $484,338.80 | |
Dec. 12, 2022 | Director | 300 | $4.98 | Buy | $1,494.00 | |
Nov. 21, 2022 | Director | 35,997 | $5.00 | Buy | $179,985.00 | |
Nov. 3, 2022 | Director | 104,090 | $4.99 | Buy | $519,409.10 | |
Oct. 27, 2022 | Director | 76,877 | $4.86 | Buy | $373,622.22 | |
Oct. 25, 2022 | Director | 51,046 | $4.75 | Buy | $242,468.50 | |
Oct. 17, 2022 | Director | 50,000 | $3.18 | Buy | $159,000.00 | |
June 2, 2022 | Director | 34,200 | $13.03 | Buy | $445,626.00 | |
May 31, 2022 | Director | 61,806 | $13.47 | Buy | $832,526.82 | |
May 26, 2022 | Director | 20,201 | $13.49 | Buy | $272,511.49 | |
May 24, 2022 | Director | 17,828 | $13.37 | Buy | $238,360.36 | |
May 19, 2022 | Director | 20,666 | $13.25 | Buy | $273,824.50 | |
May 17, 2022 | Director | 89,049 | $13.42 | Buy | $1,195,037.58 | |
May 11, 2022 | Director | 83,175 | $11.25 | Buy | $935,718.75 | |
May 9, 2022 | Director | 83,175 | $10.79 | Buy | $897,458.25 | |
Dec. 6, 2021 | Insider | 15,000 | $18.21 | Sell | $273,150.00 | |
Nov. 18, 2021 | CEO | 15,000 | $20.02 | Sell | $300,300.00 | |
Nov. 15, 2021 | Insider | 30,000 | $19.73 | Sell | $591,900.00 | |
Oct. 11, 2021 | Insider | 15,000 | $20.41 | Sell | $306,150.00 | |
Oct. 5, 2021 | SVP | 2,000 | $22.00 | Sell | $44,000.00 | |
Sept. 13, 2021 | Insider | 15,000 | $26.03 | Sell | $390,450.00 | |
Aug. 9, 2021 | Insider | 15,000 | $24.46 | Sell | $366,900.00 | |
April 12, 2021 | Insider | 25,000 | $24.65 | Sell | $616,250.00 | |
March 1, 2021 | Insider | 25,000 | $26.66 | Sell | $666,500.00 | |
Jan. 4, 2021 | Insider | 25,000 | $29.28 | Sell | $732,000.00 | |
Dec. 14, 2020 | Insider | 25,000 | $28.01 | Sell | $700,250.00 | |
Oct. 12, 2020 | Insider | 25,000 | $17.02 | Sell | $425,500.00 | |
Sept. 1, 2020 | Insider | 25,000 | $17.83 | Sell | $445,750.00 | |
Sept. 1, 2020 | Director | 36,494 | $17.64 | Buy | $643,754.16 | |
Aug. 27, 2020 | Director | 36,359 | $17.79 | Buy | $646,826.61 | |
Aug. 24, 2020 | Director | 11,024 | $17.96 | Buy | $197,991.04 | |
Aug. 21, 2020 | Director | 7,321 | $17.97 | Buy | $131,558.37 | |
Aug. 17, 2020 | Director | 6,425 | $17.89 | Buy | $114,943.25 | |
Aug. 13, 2020 | Director | 19,895 | $17.89 | Buy | $355,921.55 | |
July 30, 2020 | Director | 732 | $17.99 | Buy | $13,168.68 | |
July 27, 2020 | Director | 3,834 | $17.99 | Buy | $68,973.66 | |
July 24, 2020 | Director | 68,749 | $17.93 | Buy | $1,232,669.57 | |
July 22, 2020 | Director | 193 | $18.00 | Buy | $3,474.00 | |
July 1, 2020 | Insider | 25,000 | $18.91 | Sell | $472,750.00 | |
June 15, 2020 | Insider | 25,000 | $21.65 | Sell | $541,250.00 | |
May 15, 2020 | SVP | 1,562 | $22.00 | Sell | $34,364.00 | |
April 7, 2020 | Director | 123,728 | $14.38 | Buy | $1,779,208.64 | |
April 7, 2020 | Major Shareholder | 138,315 | $14.19 | Buy | $1,962,689.85 | |
April 2, 2020 | Major Shareholder | 250,984 | $12.78 | Buy | $3,207,575.52 | |
April 2, 2020 | Director | 14,850 | $12.40 | Buy | $184,140.00 |
Insiders are both buying and selling NGM Biopharmaceuticals Inc stock.
The insider traders at NGM Biopharmaceuticals Inc are: Group L P Column, Jin-Long Chen, Peter Svennilson, David V Goeddel, David J Woodhouse, Suzanne Sawochka Hooper, Hsiao D Lieu, Hsiao D. Lieu, and Merck & Co., Inc.
The most active insider trader at NGM Biopharmaceuticals Inc is Group L P Column with 51 trades.
Jin-Long Chen has sold the most NGM Biopharmaceuticals Inc stock with a total value of $8,675,781.10.
Merck & Co., Inc. has bought the most NGM Biopharmaceuticals Inc stock with a total value of $131,893,856.00.
The most recent insider trade for NGM Biopharmaceuticals Inc was on Jan. 30, 2023.
The single biggest insider buy for NGM Biopharmaceuticals Inc was from Merck & Co., Inc. with a total value of $65,946,928.00 on April 8, 2019.
The single biggest insider sell for NGM Biopharmaceuticals Inc was from Group L P Column with a total value of $2,403,568.72 on Oct. 21, 2019.